This report contains market size and forecasts of NGS-based RNA-seq in Global, including the following market information:
Global NGS-based RNA-seq Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global NGS-based RNA-seq market was valued at 1578.9 million in 2020 and is projected to reach US$ 2380.8 million by 2027, at a CAGR of 10.8% during the forecast period.
Publisher has surveyed the NGS-based RNA-seq companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NGS-based RNA-seq Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global NGS-based RNA-seq Market Segment Percentages, By Type, 2020 (%)
High-Throughput Sequencing
Third-Generation Sequencing Technology
China NGS-based RNA-seq Market, By Application, 2016-2021, 2022-2027 ($ millions)
China NGS-based RNA-seq Market Segment Percentages, By Application, 2020 (%)
Hospitals and Clinics
Biopharma Companies
Government Agencies
Academic and Research Organizations
Other
Global NGS-based RNA-seq Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global NGS-based RNA-seq Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total NGS-based RNA-seq Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total NGS-based RNA-seq Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Illumina
Thermo Fisher Scientific
Pacific Biosciences Of California
Qaigen
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 NGS-based RNA-seq Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NGS-based RNA-seq Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NGS-based RNA-seq Overall Market Size
2.1 Global NGS-based RNA-seq Market Size: 2021 VS 2027
2.2 Global NGS-based RNA-seq Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top NGS-based RNA-seq Players in Global Market
3.2 Top Global NGS-based RNA-seq Companies Ranked by Revenue
3.3 Global NGS-based RNA-seq Revenue by Companies
3.4 Top 3 and Top 5 NGS-based RNA-seq Companies in Global Market, by Revenue in 2020
3.5 Global Companies NGS-based RNA-seq Product Type
3.6 Tier 1, Tier 2 and Tier 3 NGS-based RNA-seq Players in Global Market
3.6.1 List of Global Tier 1 NGS-based RNA-seq Companies
3.6.2 List of Global Tier 2 and Tier 3 NGS-based RNA-seq Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global NGS-based RNA-seq Market Size Markets, 2021 & 2027
4.1.2 High-Throughput Sequencing
4.1.3 Third-Generation Sequencing Technology
4.2 By Type - Global NGS-based RNA-seq Revenue & Forecasts
4.2.1 By Type - Global NGS-based RNA-seq Revenue, 2016-2021
4.2.2 By Type - Global NGS-based RNA-seq Revenue, 2022-2027
4.2.3 By Type - Global NGS-based RNA-seq Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global NGS-based RNA-seq Market Size, 2021 & 2027
5.1.2 Hospitals and Clinics
5.1.3 Biopharma Companies
5.1.4 Government Agencies
5.1.5 Academic and Research Organizations
5.1.6 Other
5.2 By Application - Global NGS-based RNA-seq Revenue & Forecasts
5.2.1 By Application - Global NGS-based RNA-seq Revenue, 2016-2021
5.2.2 By Application - Global NGS-based RNA-seq Revenue, 2022-2027
5.2.3 By Application - Global NGS-based RNA-seq Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global NGS-based RNA-seq Market Size, 2021 & 2027
6.2 By Region - Global NGS-based RNA-seq Revenue & Forecasts
6.2.1 By Region - Global NGS-based RNA-seq Revenue, 2016-2021
6.2.2 By Region - Global NGS-based RNA-seq Revenue, 2022-2027
6.2.3 By Region - Global NGS-based RNA-seq Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America NGS-based RNA-seq Revenue, 2016-2027
6.3.2 US NGS-based RNA-seq Market Size, 2016-2027
6.3.3 Canada NGS-based RNA-seq Market Size, 2016-2027
6.3.4 Mexico NGS-based RNA-seq Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe NGS-based RNA-seq Revenue, 2016-2027
6.4.2 Germany NGS-based RNA-seq Market Size, 2016-2027
6.4.3 France NGS-based RNA-seq Market Size, 2016-2027
6.4.4 U.K. NGS-based RNA-seq Market Size, 2016-2027
6.4.5 Italy NGS-based RNA-seq Market Size, 2016-2027
6.4.6 Russia NGS-based RNA-seq Market Size, 2016-2027
6.4.7 Nordic Countries NGS-based RNA-seq Market Size, 2016-2027
6.4.8 Benelux NGS-based RNA-seq Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia NGS-based RNA-seq Revenue, 2016-2027
6.5.2 China NGS-based RNA-seq Market Size, 2016-2027
6.5.3 Japan NGS-based RNA-seq Market Size, 2016-2027
6.5.4 South Korea NGS-based RNA-seq Market Size, 2016-2027
6.5.5 Southeast Asia NGS-based RNA-seq Market Size, 2016-2027
6.5.6 India NGS-based RNA-seq Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America NGS-based RNA-seq Revenue, 2016-2027
6.6.2 Brazil NGS-based RNA-seq Market Size, 2016-2027
6.6.3 Argentina NGS-based RNA-seq Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa NGS-based RNA-seq Revenue, 2016-2027
6.7.2 Turkey NGS-based RNA-seq Market Size, 2016-2027
6.7.3 Israel NGS-based RNA-seq Market Size, 2016-2027
6.7.4 Saudi Arabia NGS-based RNA-seq Market Size, 2016-2027
6.7.5 UAE NGS-based RNA-seq Market Size, 2016-2027
7 Players Profiles
7.1 Illumina
7.1.1 Illumina Corporate Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina NGS-based RNA-seq Major Product Offerings
7.1.4 Illumina NGS-based RNA-seq Revenue in Global (2016-2021)
7.1.5 Illumina Key News
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Corporate Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific NGS-based RNA-seq Major Product Offerings
7.2.4 Thermo Fisher Scientific NGS-based RNA-seq Revenue in Global (2016-2021)
7.2.5 Thermo Fisher Scientific Key News
7.3 Pacific Biosciences Of California
7.3.1 Pacific Biosciences Of California Corporate Summary
7.3.2 Pacific Biosciences Of California Business Overview
7.3.3 Pacific Biosciences Of California NGS-based RNA-seq Major Product Offerings
7.3.4 Pacific Biosciences Of California NGS-based RNA-seq Revenue in Global (2016-2021)
7.3.5 Pacific Biosciences Of California Key News
7.4 Qaigen
7.4.1 Qaigen Corporate Summary
7.4.2 Qaigen Business Overview
7.4.3 Qaigen NGS-based RNA-seq Major Product Offerings
7.4.4 Qaigen NGS-based RNA-seq Revenue in Global (2016-2021)
7.4.5 Qaigen Key News
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Corporate Summary
7.5.2 F. Hoffmann-La Roche Business Overview
7.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Major Product Offerings
7.5.4 F. Hoffmann-La Roche NGS-based RNA-seq Revenue in Global (2016-2021)
7.5.5 F. Hoffmann-La Roche Key News
7.6 Agilent Technologies
7.6.1 Agilent Technologies Corporate Summary
7.6.2 Agilent Technologies Business Overview
7.6.3 Agilent Technologies NGS-based RNA-seq Major Product Offerings
7.6.4 Agilent Technologies NGS-based RNA-seq Revenue in Global (2016-2021)
7.6.5 Agilent Technologies Key News
7.7 Oxford Nanopore Technologies
7.7.1 Oxford Nanopore Technologies Corporate Summary
7.7.2 Oxford Nanopore Technologies Business Overview
7.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Major Product Offerings
7.4.4 Oxford Nanopore Technologies NGS-based RNA-seq Revenue in Global (2016-2021)
7.7.5 Oxford Nanopore Technologies Key News
7.8 Perkinelmer
7.8.1 Perkinelmer Corporate Summary
7.8.2 Perkinelmer Business Overview
7.8.3 Perkinelmer NGS-based RNA-seq Major Product Offerings
7.8.4 Perkinelmer NGS-based RNA-seq Revenue in Global (2016-2021)
7.8.5 Perkinelmer Key News
7.9 Eurofins Scientific
7.9.1 Eurofins Scientific Corporate Summary
7.9.2 Eurofins Scientific Business Overview
7.9.3 Eurofins Scientific NGS-based RNA-seq Major Product Offerings
7.9.4 Eurofins Scientific NGS-based RNA-seq Revenue in Global (2016-2021)
7.9.5 Eurofins Scientific Key News
7.10 Gatc Biotech
7.10.1 Gatc Biotech Corporate Summary
7.10.2 Gatc Biotech Business Overview
7.10.3 Gatc Biotech NGS-based RNA-seq Major Product Offerings
7.10.4 Gatc Biotech NGS-based RNA-seq Revenue in Global (2016-2021)
7.10.5 Gatc Biotech Key News
7.11 Macrogen
7.11.1 Macrogen Corporate Summary
7.11.2 Macrogen Business Overview
7.11.3 Macrogen NGS-based RNA-seq Major Product Offerings
7.11.4 Macrogen NGS-based RNA-seq Revenue in Global (2016-2021)
7.11.5 Macrogen Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. NGS-based RNA-seq Market Opportunities & Trends in Global Market
Table 2. NGS-based RNA-seq Market Drivers in Global Market
Table 3. NGS-based RNA-seq Market Restraints in Global Market
Table 4. Key Players of NGS-based RNA-seq in Global Market
Table 5. Top NGS-based RNA-seq Players in Global Market, Ranking by Revenue (2019)
Table 6. Global NGS-based RNA-seq Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global NGS-based RNA-seq Revenue Share by Companies, 2016-2021
Table 8. Global Companies NGS-based RNA-seq Product Type
Table 9. List of Global Tier 1 NGS-based RNA-seq Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 NGS-based RNA-seq Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global NGS-based RNA-seq Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - NGS-based RNA-seq Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - NGS-based RNA-seq Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global NGS-based RNA-seq Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - NGS-based RNA-seq Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - NGS-based RNA-seq Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global NGS-based RNA-seq Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global NGS-based RNA-seq Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global NGS-based RNA-seq Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America NGS-based RNA-seq Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America NGS-based RNA-seq Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe NGS-based RNA-seq Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe NGS-based RNA-seq Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia NGS-based RNA-seq Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia NGS-based RNA-seq Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America NGS-based RNA-seq Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America NGS-based RNA-seq Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa NGS-based RNA-seq Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa NGS-based RNA-seq Revenue, (US$, Mn), 2022-2027
Table 30. Illumina Corporate Summary
Table 31. Illumina NGS-based RNA-seq Product Offerings
Table 32. Illumina NGS-based RNA-seq Revenue (US$, Mn), (2016-2021)
Table 33. Thermo Fisher Scientific Corporate Summary
Table 34. Thermo Fisher Scientific NGS-based RNA-seq Product Offerings
Table 35. Thermo Fisher Scientific NGS-based RNA-seq Revenue (US$, Mn), (2016-2021)
Table 36. Pacific Biosciences Of California Corporate Summary
Table 37. Pacific Biosciences Of California NGS-based RNA-seq Product Offerings
Table 38. Pacific Biosciences Of California NGS-based RNA-seq Revenue (US$, Mn), (2016-2021)
Table 39. Qaigen Corporate Summary
Table 40. Qaigen NGS-based RNA-seq Product Offerings
Table 41. Qaigen NGS-based RNA-seq Revenue (US$, Mn), (2016-2021)
Table 42. F. Hoffmann-La Roche Corporate Summary
Table 43. F. Hoffmann-La Roche NGS-based RNA-seq Product Offerings
Table 44. F. Hoffmann-La Roche NGS-based RNA-seq Revenue (US$, Mn), (2016-2021)
Table 45. Agilent Technologies Corporate Summary
Table 46. Agilent Technologies NGS-based RNA-seq Product Offerings
Table 47. Agilent Technologies NGS-based RNA-seq Revenue (US$, Mn), (2016-2021)
Table 48. Oxford Nanopore Technologies Corporate Summary
Table 49. Oxford Nanopore Technologies NGS-based RNA-seq Product Offerings
Table 50. Oxford Nanopore Technologies NGS-based RNA-seq Revenue (US$, Mn), (2016-2021)
Table 51. Perkinelmer Corporate Summary
Table 52. Perkinelmer NGS-based RNA-seq Product Offerings
Table 53. Perkinelmer NGS-based RNA-seq Revenue (US$, Mn), (2016-2021)
Table 54. Eurofins Scientific Corporate Summary
Table 55. Eurofins Scientific NGS-based RNA-seq Product Offerings
Table 56. Eurofins Scientific NGS-based RNA-seq Revenue (US$, Mn), (2016-2021)
Table 57. Gatc Biotech Corporate Summary
Table 58. Gatc Biotech NGS-based RNA-seq Product Offerings
Table 59. Gatc Biotech NGS-based RNA-seq Revenue (US$, Mn), (2016-2021)
Table 60. Macrogen Corporate Summary
Table 61. Macrogen NGS-based RNA-seq Product Offerings
Table 62. Macrogen NGS-based RNA-seq Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. NGS-based RNA-seq Segment by Type
Figure 2. NGS-based RNA-seq Segment by Application
Figure 3. Global NGS-based RNA-seq Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global NGS-based RNA-seq Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global NGS-based RNA-seq Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by NGS-based RNA-seq Revenue in 2020
Figure 8. By Type - Global NGS-based RNA-seq Revenue Market Share, 2016-2027
Figure 9. By Application - Global NGS-based RNA-seq Revenue Market Share, 2016-2027
Figure 10. By Region - Global NGS-based RNA-seq Revenue Market Share, 2016-2027
Figure 11. By Country - North America NGS-based RNA-seq Revenue Market Share, 2016-2027
Figure 12. US NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 13. Canada NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe NGS-based RNA-seq Revenue Market Share, 2016-2027
Figure 16. Germany NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 17. France NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 19. Italy NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 20. Russia NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia NGS-based RNA-seq Revenue Market Share, 2016-2027
Figure 24. China NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 25. Japan NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 28. India NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America NGS-based RNA-seq Revenue Market Share, 2016-2027
Figure 30. Brazil NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa NGS-based RNA-seq Revenue Market Share, 2016-2027
Figure 33. Turkey NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 34. Israel NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 36. UAE NGS-based RNA-seq Revenue, (US$, Mn), 2016-2027
Figure 37. Illumina NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Thermo Fisher Scientific NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Pacific Biosciences Of California NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Qaigen NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. F. Hoffmann-La Roche NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Agilent Technologies NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Oxford Nanopore Technologies NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Perkinelmer NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Eurofins Scientific NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Gatc Biotech NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Macrogen NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Illumina
Thermo Fisher Scientific
Pacific Biosciences Of California
Qaigen
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen